Company Overview

NIAGEN BIOSCIENCE, INC.

NAGE
Annual
Revenue vs. Cost of Revenue
Revenue Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses Operating Income
Net Income
Net Income
Revenue
129M
2025 FY
Net Income
17M
2025 FY
Shares Outstanding
79M
2025 FY
EPS
0.22USD
2025 FY
Company Information
SIC Code
2833
CIK Code
1386570
Exchange
Nasdaq
Location
US